Drug Discovery World

SEPTEMBER 6, 2022

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. billion, compared to $19.9

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

XTalks

AUGUST 2, 2023

In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine. The order of the companies presented in this article is based on their 2022 full year or fiscal year revenue. percent increase from its 2021 revenue of $81.29

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 19, 2023

This list not only highlights the drugs that have achieved significant commercial success but also reflects the prevailing health challenges and the pharmaceutical industry’s response to them. In this article, we will explore the factors contributing to the success of the top 20 drugs in 2023 by retail sales from the prior year.

Sales 64

Sales FDA Approval Drugs Vaccination 64